Glaxosmithkline Pharmaceuticals informs about analyst meet

11 Feb 2025 Evaluate
Pursuant to Regulation 30 read with para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Glaxosmithkline Pharmaceuticals has informed that an group analyst meeting is scheduled on 14th February 2025 via Digital.

The above information is a part of company’s filings submitted to BSE.


Glaxosmithkline Phar Share Price

2560.00 -0.05 (0.00%)
10-Dec-2025 09:23 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1771.30
Dr. Reddys Lab 1248.70
Cipla 1488.70
Zydus Lifesciences 926.25
Lupin 2060.30
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×